Caxton Associates (UK)’s Aveanna Healthcare AVAH Stock Holding History
Bought
Maintained
Sold
Other funds holding AVAH
BCI
JHWEPV
NTCM
SP
VCM
B
LC
N
Caxton Associates (UK)'s AVAH Position: Q1 2026 in Review
Caxton Associates (UK) sold out of Aveanna Healthcare (AVAH) in Q1 2026, closing a stake of 67,593 shares — an estimated $552K sold.
Caxton Associates (UK) first reported a position in AVAH in Q3 2025 and held it in 2 quarters. The position peaked at $552K in Q4 2025. 198 funds tracked by Wall St. Rank hold AVAH as of Q1 2026.
- Caxton Associates (UK) reported no remaining Aveanna Healthcare position as of Q1 2026 after selling out during the quarter.
- Caxton Associates (UK) sold 67,593 Aveanna Healthcare shares in Q1 2026, an estimated $552K.
- Caxton Associates (UK) first reported a position in Aveanna Healthcare in Q3 2025 and held it in 2 quarters.
- Caxton Associates (UK)'s Aveanna Healthcare position peaked at $552K in Q4 2025.
- 198 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q1 2026.
Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.